Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 17 citing articles:

Efficacy of Microbiome-Targeted Interventions in Obesity Management- A comprehensive systematic review
Dhivya Dhanasekaran, M. Venkatesan, Sarvesh Sabarathinam
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 2, pp. 103208-103208
Closed Access | Times Cited: 1
Bacteroides and NAFLD: pathophysiology and therapy
Jun Zhang, Jing Zhou, Zheyun He, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial
Farnoush Fallah, Reza Mahdavi
Probiotics and Antimicrobial Proteins (2025)
Closed Access
A comprehensive review of synbiotics: an emerging paradigm in health promotion and disease management
Sulhee Lee, Sang-Pil Choi, Hak‐Jong Choi, et al.
World Journal of Microbiology and Biotechnology (2024) Vol. 40, Iss. 9
Closed Access | Times Cited: 4
The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: a systematic review and meta-analysis of randomized controlled trials
Vali Musazadeh, Kimia Assadian, Fatemeh Rajabi, et al.
Pharmacological Research (2024) Vol. 208, pp. 107398-107398
Open Access | Times Cited: 4
The therapeutic success of approaches to the gastrointestinal microbiome modulation in the treatment of obesity, metabolic syndrome and type 2 diabetes mellitus
Anastasia A. Zabolotneva, О. П. Шатова, J. A. Agapova, et al.
Diabetes Mellitus (2025) Vol. 27, Iss. 6, pp. 598-610
Open Access
Pan-cancer analysis of NUP155 and validation of its role in breast cancer cell proliferation, migration, and apoptosis
Zi-qiong Wang, Zhixuan Wu, Zong-pan Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Plant-based probiotic foods: current state and future trends
Alan Portal D’Almeida, Aida Aguilera Infante Neta, Micael de Andrade Lima, et al.
Food Science and Biotechnology (2024) Vol. 33, Iss. 15, pp. 3401-3422
Closed Access | Times Cited: 3
Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis
Yafang Yang, Ligang Yang, Jiale Wu, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 6, pp. 1224-1239
Closed Access | Times Cited: 2
Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics
Sandra G. García, Debora Rondinella, Francesca Romana Ponziani, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101924-101924
Closed Access | Times Cited: 1
Type 2 Diabetes Mellitus and Cardiometabolic Prospects: A Rapid Narrative Review
Kona Chowdhury, Susmita Sinha, Rahnuma Ahmad, et al.
Cureus (2024)
Open Access | Times Cited: 1
Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease
Wen-wu Huang, Boyuan Shen, Xiumei Li, et al.
Foods (2023) Vol. 12, Iss. 18, pp. 3393-3393
Open Access | Times Cited: 2
The Prospect of Probiotics to Treat Metabolic Syndrome
Andika Yusuf Ramadhan, Dewi Selvina Rosdiana
Molecular and Cellular Biomedical Sciences (2024) Vol. 8, Iss. 2, pp. 71-71
Open Access
Avaliação do efeito do consumo de >i<Bifidobacterium animalis lactis HN019>/i< no controle metabólico, microbiota intestinal e na resposta imunológica de indivíduos com diabetes tipo 2
Fabiana Tannihão Folconi
(2024)
Open Access
Integrative Therapies in Metabolic Syndrome
Khara Lucius
Integrative and Complementary Therapies (2024) Vol. 30, Iss. 5, pp. 233-243
Closed Access
The role of probiotics in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD): new insights based on meta-analysis and subgroup analysis
M. Xiao, Yang Cao, Linlin Wang, et al.
Food Bioscience (2024) Vol. 62, pp. 105454-105454
Closed Access
The role of nutraceuticals in managing metabolic syndrome: a review of clinical studies
Samuel Oluwadare Olalekan, Olalekan Olanrewaju Bakare, Patrick Godwin Okwute, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access
Page 1

Scroll to top